Introduction
The usefulness of cytokines (such as interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10) and interleukin-12 (IL-12)) as markers of periimplant disease (mucositis and periimplantitis) has �een investigated (1) . The cytokines are multifunctional proteins and glycoproteins that act as intercellular regulatory factors at �oth local and systemic level. They are produced �y immunocompetent cells such as T lymphocytes and monocytes in local inflammatory tissue infiltrates. Periodontal tissue components such as fibroblasts and epithelial and endothelial cells also participate in cytokine formation during inflammatory responses (2) . Periodontal health depends on the local �alance among reactive and suppressor immune cells, their cytokines and mediators. Cytokines IL-6, IL-8 and IL-12 have proinflammatory functions, and induce bone reabsorption (1, 3) , while IL-10 exerts antiinflammatory effects (3). In the oral cavity it has �een seen that the plasma cytokine levels increase after surgery (2) . In this context, dental implant surgery releases a large amount of cytokines at local level as a �ody response to surgical aggression, and these levels gradually decrease over the su�sequent 8 months (3, 4) . Cytokine release after this period of time is regarded as an important factor in the development of periimplant disease. The present study involves a literature review of the studies relating IL-6, IL-8, IL-10 and IL-12 levels to dental implant treatment, evaluating their implication in periimplant inflammation and their influence upon osteointegration, with a view to esta�lishing whether increased cytokine concentrations in the periimplant sulcus (crevicular fluid) are correlated to an early diagnosis of periimplant disease.
Material and Method
A Pu�Med literature search was made of articles in English and Spanish, using the key words "cytokine and dental implants", cytokine and periimplantitis", "IL-6, IL-8, IL-10, IL-12 and dental implants", "IL-6, IL-8, IL-10, IL-12 and periimplantitis". Fourteen articles relating the levels of the a�ovementioned cytokines to dental implant treatment and periimplantitis were found (12 in vivo studies and two in vitro studies) -an evaluation �e-ing made of interleukin influence upon periimplant disease and the osteointegration period of dental implants in the a�sence of periimplant disease.
Results and Discussion

Influence of interleukins 6, 8, 10 and 12 upon periimplant inflammation
The increase in cytokine concentration in the crevicular fluid of dental implants may lead to a lack of osteointegration, �one loss or implant failure (5) (6) (7) . Bone is a dynamic tissue continuously su�ject to remodeling through rea�sorption and formation, these processes �eing controlled �y the local production of cytokines, among other factors (4) . Some of the studies in our review reported increased levels of IL-6, IL-8, IL-10 and IL-12 in periimplant disease, revealing their implication in the destruction of periimplant tissue and their usefulness as markers of periimplant disease (1,2,4, 7-9). In contrast, other authors o�served no relationship �etween IL-6 and IL-10 levels and periimplant disease (2, 7, 8, 10) , discarding their implication in early dental implant loss (4) . Regarding IL-6, Liskmann et al. (1), on studying the levels of IL-6 in the crevicular fluid of the periimplant sulcus in 30 patients, recorded increased concentrations in patients with periimplant disease -a positive correlation �eing o�served with the clinical parameters (�leed-ing, pocket depth and gingival index). These authors examined the usefulness of cytokine concentration as a marker of periimplant disease, and in evaluating the capacity of the patient immune system to maintain an inflammatory balance. Konttinen et al. (9) recorded higher IL-6 levels in patients with periimplantitis than in healthy su�jects -the difference �eing statistically significant. These authors concluded that periimplant disease is amena�le to treatment with cytokine modulators. In contrast, Mengel et al. (10), on comparing the IL-6 and IL-1β levels in 5 partially edentulous patients with severe periodontitis of the remaining teeth and su�-jected to dental implant reha�ilitation versus patients without periodontal disease, reported higher levels in dental implant patients with periodontitis -the difference failing to reach statistical significance. Salcetti et al. (7) likewise recorded no differences in the levels of IL-6 on comparing patients with failed implants versus those with sta�le dental implants. Campos et al. (5) , in 74 patients, analyzed the relationship �etween the polymorphic gene encoding for IL-6 and early dental implant loss. They concluded that such polymorphism does not constitute a genetic risk factor for early implant loss. Nowzari et al. (6) in turn studied cytokine and �acterial levels �etween teeth and dental implants in healthy su�-jects. An increased cytokine presence was noted in patients with dental implants (two-fold in the case of IL-8). This increase in cytokines was greater in the presence of a larger num�er of periodontal disease-inducing �ac-teria. The authors concluded that although these were healthy individuals, there is an inevita�le and continuous change in microorganisms and interleukins around teeth and implants. As regards IL-10, Liskmann et al. (1) reported a higher concentration of IL-10 in patients with periimplantitis. In contrast, Duarte et al. (8) o�served no differences �etween healthy su�jects and patients with disease. In another study, Duarte et al. (11) evaluated the efficacy of e520 mechanical treatment for mucositis and periimplantitis. An improvement in the clinical parameters was noted, together with improvement in the levels of TNF-α and the OPG/RANKL ratio three months after such treatment, without differences in the levels of IL -10 and IL-12.
On correlating IL-12 concentrations in 48 patients to plaque accumulation, pocket depth, �leeding (spontaneous or in response to pro�ing) and suppuration, Duarte et al. (8) concluded that these concentrations are higher in advanced periimplantitis, with increased plaque accumulation, bleeding and pocket depth. They identified IL-12 as a critical factor in destruction of the periodontium.
In an in vitro study, Bordin et al. (12) evaluated the fi�ro�lasts of patients with periimplantitis, patients with periodontitis, and healthy su�jects. They found that the fibroblasts of the patients with periimplantitis and periodontitis synthesized more IL-6 and IL-8, and thus presented a more accentuated proinflammatory profile (Ta�le 1).
On examining the composition of dental implants, Spyrou et al. (13) found that all titanium alloys of different compositions and roughness generated the same amount of interleukins. Influence of interleukins upon the osteointegration period of dental implants without periimplant disease Variations are o�served in the levels of cytokines in crevicular fluid from the time of dental implant surgery to one year after fitting of the prosthesis, without the obligate presence of periimplant disease. Twenty-four hours after placement of the dental implants, Pietruski et al. (14) observed a significant increase in IL-6 and IL-8 levels, thus reflecting the presence of local inflammation on the day after surgery, inherent to the surgical trauma, and forming part of the �ody regeneration and repair response. These levels in turn decreased four months after surgery. Khoury et al. (15), on exploring the influence of antibiotic prophylaxis prior to implant surgery, reported improvement in the clinical parameters one week after surgery, without modifications in cytokine levels ( Table 2 ).
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2006 ( Decrease in IL-6, IL-8, IL-10 Pietruski et al. (14) , and 8 months after prosthesis placement according to Schierano et al. (3, 4) . IL-12 does not appear under conditions of periimplant health, and disappears entirely 12 months after fitting the prosthesis.
Surgery versus maintenance:
-It is important not to confuse the rise in cytokines o�-served as a result of surgical trauma (secreted �y the �ody as part of the regeneration and repair response to injury) with the increase seen in inflammation caused by the bacterial biofilm in general, and by periodontal disease-inducing �acteria in the context of pre-esta�-lished periimplantitis. An increase in interleukins is o�served in patients with periimplant disease, though controversy exists over the effect of the interleukins in crevicular fluid and periimplantitis, regarding their correlation to implant failure or the development of periimplant disease.
